Jennifer L Proctor

age ~55

from Calvin, WV

Get Report

Also known as:

Jennifer Lynn Proctor
Jennifer C Proctor
Jesse Aaron Proctor

Phone and address:: 37 Gregory Ln, Calvin, WV 26660
3047426334

Connected to:

Jennifer Proctor Phones & Addresses

37 Gregory Ln, Calvin, WV 26660 • 3047426334
Craigsville, WV
Brookline, MA
Upperglade, WV
Mount Nebo, WV
Montgomery, WV

Medicine Doctors

Jennifer S. Proctor

view source

Specialties:

Plastic Surgery within the Head & Neck

Work:

University Of Kansas PhysiciansUniversity Of Kansas Hospital Otolaryngology
3901 Rainbow Blvd, Kansas City, KS 66160
9135886701 (phone), 9135886740 (fax)

Languages:

English
German
Spanish

Description:

Ms. Proctor works in Kansas City, KS and specializes in Plastic Surgery within the Head & Neck. Ms. Proctor is affiliated with University Of Kansas Hospital.

Name / Title

Company / Classification

Phones & Addresses

Jennifer Proctor
Cardiology

University of Kansas
Medical Doctor's Office College/University · General Hospital College/University · Noncommercial Research Organization College/University · Provides Services Bookstore Vending Machines and Food Court · Nonprofit Trust Management · Medical Doctor's Office · School/Educational Services

9135883570, 9135885900, 9135885000, 9135881400

Jennifer Proctor
Cartographer

Virginia West Conservation Agency
Conservation Office

449 Water St, Summersville, WV 26651

Resumes

Claims Supervisor

view source

Industry:

Insurance

Work:

Gallagher Bassett
Claims Supervisor

Jennifer Proctor

view source

Jennifer Proctor

view source

Jennifer Proctor

view source

Jennifer Proctor

view source

Jennifer Proctor

view source

Location:

United States

Jennifer Proctor

view source

Location:

United States

Jennifer Proctor

view source

Location:

United States

License Records

Jennifer Proctor

License #:

42001 - Active

Category:

Professional

Issued Date:

Dec 20, 2004

Expiration Date:

Mar 31, 2020

Us Patents

T-Cell Depleting Therapies
view source
US Patent:

20220249683, Aug 11, 2022
Filed:

Dec 3, 2021
Appl. No.:

17/457607
Inventors:

- Cambridge MA, US
Michael Cooke - Boston MA, US
Sean Mcdonough - Littleton MA, US
Jennifer Lynn Proctor - Medford MA, US
International Classification:

A61K 47/68
C07K 16/28
A61P 35/02
Abstract:

Provided herein are methods of depleting T cells for therapeutic uses, including administration of anti-CD2 or anti-CD5 antibody drugs conjugates (ADCs) for treatment. Provided are anti-CD2 ADCs or anti-CD5 ADCs for use as agents to treat a stem cell disorder, cancer, or autoimmune disease, among other hematological and proliferative diseases. The compositions and methods described can be used to deplete populations of CD2+ or CD5+ cells, such as CD2+ or CD5+ cancer cells or CD2+ or CD5+ immune cells, and can also be used to prepare a patient for hematopoietic stem cell transplantation or solid organ transplantation.

Methods For Allogeneic Hematopoietic Stem Cell Transplantation
view source
US Patent:

20210379195, Dec 9, 2021
Filed:

Apr 29, 2021
Appl. No.:

17/244864
Inventors:

- Cambridge MA, US
Jennifer Lynn Proctor - Medford MA, US
Geoffrey O. Gillard - Harvard MA, US
Anthony Boitano - Newton MA, US
Sharon Hyzy - Malden MA, US
Michael Cooke - Boston MA, US
Adam Hartigan - Brookline MA, US
International Classification:

A61K 47/68
A61K 31/675
A61K 35/28
A61P 37/06
Abstract:

Described herein are compositions and methods useful for the depletion of CD117+ or CD45+ cells and for the treatment of various hematopoietic diseases, metabolic disorders, cancers, and autoimmune diseases, among others. The compositions and methods described herein can be used to treat a disorder, for instance, by depleting a population of CD117+ or CD45+ cancer cells or autoimmune cells. The compositions and methods described herein can also be used to prepare a patient for allogeneic hematopoietic stem cell transplant therapy and to improve the engraftment of allogeneic hematopoietic stem cell transplants by selectively depleting endogenous hematopoietic stem cells prior to the transplant procedure.

Therapeutic Methods Using Antibody Drug Conjugates (Adcs)
view source
US Patent:

20210283267, Sep 16, 2021
Filed:

Dec 4, 2020
Appl. No.:

17/111816
Inventors:

- Cambridge MA, US
Michael Cooke - Boston MA, US
Jennifer Lynn Proctor - Medford MA, US
Charlotte Fenton McDonagh - Winchester MA, US
International Classification:

A61K 47/68
C07K 16/28
A61K 35/28
A61K 47/65
Abstract:

The invention relates to dosing regimens for antibody drug conjugates, as well as methods of administering said dosing regimens to patients suffering from or at risk of various diseases and conditions such as autoimmune diseases, cancers, and Graft versus Host Disease (GvHD), among others, by administration of an antibody drug conjugate (ADC), capable of binding an antigen expressed by a hematopoietic cell, such as a hematopoietic stem cell, an immune cell or a cancer cell.

News

Investigators probe cause of armed fighter jet crash at Ellington Airport

view source

The pilot, who was conducting a training flight, ejected and was taken to an area hospital. His name is not being released due to the pending investigation, Barker said. The pilot is apparently assigned to the 138th Fighter Wing, according to Capt. Jennifer Proctor, a public affairs officer there.
Date: Jun 21, 2017
Category: U.S.
Source: Google